{
    "2018-03-14": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Orexigen Plummets on Filing of Chapter 11 of Bankruptcy Code",
                "features": {
                    "keywords": [
                        "Orexigen",
                        "Plummets",
                        "Chapter 11",
                        "Bankruptcy"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Novartis’s Innovative Medicines Business in 4Q17",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Innovative Medicines",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "How Novartis’s Business Segments Performed in 4Q17",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Business Segments",
                        "4Q17"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}